HCA Healthcare Dirección
Dirección controles de criterios 2/4
HCA Healthcare's El consejero delegado es Sam Hazen , nombrado en Jan 2019, tiene un mandato de 4.92 años. la remuneración anual total es $14.64M , compuesta por 10.3% salario y 89.7% primas, incluidas acciones y opciones de la empresa. posee directamente 0.48% de las acciones de la empresa, por valor de $334.63M . La antigüedad media del equipo directivo y del consejo de administración es de 4.9 años y 7.9 años respectivamente.
Información clave
Sam Hazen
Chief Executive Officer (CEO)
US$21.3m
Compensación total
| Porcentaje del salario del CEO | 7.1% |
| Permanencia del CEO | 5.3yrs |
| Participación del CEO | 0.5% |
| Permanencia media de la dirección | 5.3yrs |
| Promedio de permanencia en la Junta Directiva | 8.2yrs |
Actualizaciones recientes de la dirección
Recent updates
Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11
HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jan 21At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Jan 08HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings
Dec 25HCA Healthcare Continues To Impress
Dec 14Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?
Dec 11HCA Remains Attractive Despite A JV Misstep
Nov 20These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively
Oct 26HCA Healthcare: Rx For Success
Oct 10A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital
Oct 09HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?
Sep 17HCA Healthcare Is Beating The Industry
Sep 13Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly
Jul 25HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns
Jul 10HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price
Jun 25Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jun 09HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60
May 25HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet
Apr 22HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital
Apr 04Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?
Mar 16At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Feb 26HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jan 30HCA Healthcare Q4 2022 Earnings Preview
Jan 26HCA Healthcare: An Investment For Interesting Times
Jan 13Investors Shouldn't Overlook The Favourable Returns On Capital At HCA Healthcare (NYSE:HCA)
Jan 04HCA Healthcare: Earnings Growth Ahead With A Below-Market P/E, Shares Appear Attractive
Dec 16HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Dec 16Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
Nov 28HCA Healthcare Q3 2022 Earnings Preview
Oct 20HCA Healthcare's Improving 2023 Margins Make It An Attractive Stock
Oct 04Does HCA Healthcare (NYSE:HCA) Deserve A Spot On Your Watchlist?
Sep 23HCA Healthcare (NYSE:HCA) Is Reinvesting To Multiply In Value
Sep 05Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$15m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$7b |
| Dec 31 2021 | US$21m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$5b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$30m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$27m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$10m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$3b |
| Mar 31 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$10m | US$1m | US$2b |
Compensación vs. Mercado: Sam($USD21.32M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD12.14M).
Compensación vs. Ingresos: Samha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.
CEO
Sam Hazen (63 yo)
5.3yrs
Permanencia
US$21,315,984
Compensación
Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 5.3yrs | US$21.32m | 0.50% $ 427.8m | |
| Executive VP & CFO | 10.3yrs | US$7.76m | 0.069% $ 58.8m | |
| Executive VP & COO | 1.3yrs | US$8.70m | 0.057% $ 48.8m | |
| President of American Group | 11.3yrs | US$5.40m | 0.046% $ 38.9m | |
| President of National Group | 7.8yrs | US$5.58m | 0.0089% $ 7.6m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.18% $ 154.6m | |
| Senior VP & Chief Information Officer | less than a year | sin datos | 0.00060% $ 512.3k | |
| Executive VP and Chief Legal & Administrative Officer | 2.3yrs | US$6.47m | 0.0015% $ 1.3m | |
| Vice President of Investor Relations | 2.3yrs | sin datos | sin datos | |
| Senior VP and Chief Ethics & Compliance Officer | 5.3yrs | sin datos | 0.0048% $ 4.1m | |
| Senior Vice President of Marketing & Corporate Affairs | 6.5yrs | sin datos | 0.0026% $ 2.2m | |
| Senior VP & Chief Human Resources Officer | 4.4yrs | sin datos | 0.0071% $ 6.0m |
5.3yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: HCAEl equipo directivo de la empresa es veterano y experimentado (5.2 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 5.6yrs | US$21.32m | 0.50% $ 427.8m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.18% $ 154.6m | |
| Independent Director | 6.3yrs | US$389.78k | 0% $ 0 | |
| Independent Director | 10.2yrs | US$377.95k | 0.0015% $ 1.3m | |
| Independent Director | 10.2yrs | US$334.78k | 0.0074% $ 6.3m | |
| Chairman of the Board | 18.3yrs | US$399.61k | 0% $ 0 | |
| Independent Director | 5.1yrs | US$319.78k | 0% $ 0 | |
| Independent Director | 2.6yrs | US$339.78k | 0% $ 0 | |
| Independent Director | 12.3yrs | US$349.78k | 0.0041% $ 3.5m | |
| Director | 15.3yrs | US$309.70k | 0.15% $ 131.0m | |
| Independent Director | 2.3yrs | US$324.78k | 0.00047% $ 401.3k | |
| Director of HealthONE | no data | sin datos | sin datos |
8.2yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de HCA se considera experimentada (7.9 años de antigüedad promedio).